Loading chart…
PRE-MARKET
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease; and Seretide.
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The GLAXO share price is ₹2,524.80 (+1.03% today), with a market capitalisation of ₹428B and a price-to-earnings (P/E) ratio of 37.3. MarketRipple tracks the GLAXO investment thesis, the ripple-chain impact of market events on GlaxoSmithKline Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹2,529.80
High
₹2,547.60
Low
₹2,524.80
Prev. Close
₹2,499.00
52W High
₹3,120.70
52W Low
₹2,088.10
Day range
₹2,524.80–₹2,547.60
52-week range
₹2,088.10–₹3,120.70
Volume
4K
P/E
37.3
ROE
63.9%
D/E
0.01
Margin
27.3%
GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO) is currently trading at ₹2,524.80 (+1.03%).
GlaxoSmithKline Pharmaceuticals Limited's market capitalization is ₹428B.
GlaxoSmithKline Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 37.3.
GlaxoSmithKline Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - General).
Analyst consensus on GlaxoSmithKline Pharmaceuticals Limited currently reads strongly positive, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.